Related Experiment Videos

Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response

Jeffrey M Labasi1, Nina Petrushova, Carol Donovan

  • 1Department of Antibacterials, Immunology, and Inflammation, Pfizer Global Research and Development, Pfizer Inc., Groton, CT 06340, USA.

Insights

Extracellular ATP activates leukocytes via the P2X(7) receptor (P2X(7)R), a key player in inflammation. P2X(7)R deficiency significantly reduces leukocyte activation and inflammatory responses in arthritis models.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Leukocytes respond to extracellular ATP through the P2X(7) receptor (P2X(7)R).
  • P2X(7)R is an ion channel involved in cellular activation and inflammatory mediator release.
  • The role of P2X(7)R in vivo inflammatory conditions requires further elucidation.

Purpose of the Study:

  • To investigate the functional role of the P2X(7) receptor in leukocyte activation.
  • To determine the involvement of P2X(7)R in the inflammatory response during an in vivo arthritis model.

Main Methods:

  • Characterization of leukocytes from P2X(7)R-deficient and wild-type mice.
  • Assessment of leukocyte responses (volume changes, L-selectin shedding) to ATP stimulation.
  • Analysis of IL-1 beta release following LPS and ATP co-stimulation.
  • Induction of anti-collagen antibody-induced arthritis in P2X(7)R-deficient and wild-type mice, followed by LPS challenge.

Main Results:

  • Wild-type leukocytes responded to ATP with volume changes and L-selectin shedding, unlike P2X(7)R-deficient leukocytes.
  • Sequential LPS and ATP stimulation induced significant IL-1 beta release in wild-type blood but not in P2X(7)R-deficient blood.
  • P2X(7)R-deficient mice exhibited significantly reduced incidence and severity of arthritis, including less joint inflammation and cartilage damage, compared to wild-type mice.

Conclusions:

  • Extracellular ATP acts via the P2X(7) receptor to modulate leukocyte function.
  • The P2X(7) receptor is a critical mediator of inflammatory responses in vivo.
  • Targeting the P2X(7) receptor may offer a therapeutic strategy for inflammatory diseases like arthritis.

Related Concept Videos